So I suppose you wanna take us through sort of like, yeah, your profitability and your cash and, uh, how the business sets up going forward.

Yeah.

Never been told I'm gonna take the roof off, but, uh, hey, let's, uh, let's have a look at this.

So yeah, it's nice to slightly overachieve again i- in the year.

Uh, we like to over... uh, underpromise and overachieve.

So the...

Yeah.

I- in terms of just broadly Q1 trading all, all in line, I guess, with, um, thoughts for the, uh, expectations for the full year?

How many of you

use Google or Apple Maps to get here? How many of you use Word? Remember Clippy? You're all using AI, you just don't know about it.

So even the use of AI in business by individuals is not particularly new.

So first key message is generative AI is really just the most recent stage of an ongoing technological revolution.

It's been going on for decades and it's great for Australia, but we've got more to come.

Second message.

All technological change brings change.

So I suppose my question is, in terms of regulatory capacity and simplification, what do you expect from Australia? Do you have hope that we can get there? What are the challenges or maybe a way of framing it? How can we make sure that we don't let our regulation stop us from both capitalising on the opportunities and from appropriately managing the risks that arise from the geostrategic context?

That's revenue cover, is it, for this year and for next year? Yeah.

Yeah, for AES.

Medicals are slightly different because they've got shorter-term product, etc.

They'd be probably 60% covered for this year.

We'll come back to the reasons for that in a little while.

But revenue, pretty static there at around about £78-79 million, which is good.

Gross margin slightly ticked up to £31.7 million.

How do you see that one sort of like panning out?